Insider Transactions in Q4 2020 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+24.57%
|
$72,000
$9.2 P/Share
|
|
Dec 14
2020
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
5,714
-100.0%
|
$525,688
$92.64 P/Share
|
|
Dec 14
2020
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
5,714
+50.0%
|
$11,428
$2.92 P/Share
|
|
Dec 14
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+21.55%
|
$25,000
$2.92 P/Share
|
|
Dec 10
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-5.16%
|
$470,000
$94.82 P/Share
|
|
Dec 10
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.87%
|
$40,000
$8.24 P/Share
|
|
Nov 12
2020
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,264
+50.0%
|
-
|
|
Nov 12
2020
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.46%
|
-
|
|
Nov 12
2020
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
1,757
+50.0%
|
-
|
|
Nov 12
2020
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.46%
|
-
|
|
Nov 12
2020
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$480,000
$96.84 P/Share
|
|
Nov 12
2020
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.92 P/Share
|
|
Nov 12
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
8,334
-20.16%
|
$833,400
$100.0 P/Share
|
|
Nov 12
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+16.78%
|
$75,006
$9.2 P/Share
|
|
Nov 11
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
8,333
-20.16%
|
$833,300
$100.01 P/Share
|
|
Nov 11
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+16.78%
|
$74,997
$9.2 P/Share
|
|
Nov 10
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
13,333
-16.51%
|
$1,373,299
$103.8 P/Share
|
|
Nov 10
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
13,333
+14.01%
|
$106,664
$8.24 P/Share
|
|
Nov 10
2020
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
118
-2.31%
|
$12,154
$103.48 P/Share
|
|
Nov 10
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
118
+2.25%
|
$1,062
$9.2 P/Share
|
|
Nov 09
2020
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,318
-41.2%
|
$987,708
$106.64 P/Share
|
|
Nov 09
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,318
+27.68%
|
$83,862
$9.2 P/Share
|
|
Nov 06
2020
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
564
-10.14%
|
$60,912
$108.15 P/Share
|
|
Nov 06
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
564
+9.2%
|
$5,076
$9.2 P/Share
|
|
Nov 03
2020
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$425,000
$85.0 P/Share
|
|
Nov 03
2020
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.92 P/Share
|
|
Oct 12
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-13.16%
|
$390,000
$78.67 P/Share
|
|
Oct 12
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.63%
|
$35,000
$7.27 P/Share
|